Floatz logo

Aspirin

Portal Hypertension

Northern Jiangsu People's HospitalSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Portal Hypertension cohort.

Asset / SponsorPhaseRating
Carvedilol
West China Hospital
Phase 4BBB
Simvastatin
Kafrelsheikh University
Phase 4BBB
Apsolol
West China Hospital
Phase 4BBB
Apixaban
Asian Institute Of Medical Sciences
Phase 4BB
Lactulose
University of Michigan
Phase 4BB

View all 50 →

Same molecule, other indications

Aspirin is also rated in:

myocardial infarctionActive
A
Indicative · Phase 4
83 / 100
View asset →
coronary artery disorderActive
BBB
Indicative · Phase 4
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →